NAACCR Item #3896: NCCN International Prognostic Index (IPI)
| Item # | Length | Source of Standard | Year Implemented | Version Implemented | Year Retired | Version Retired |
|---|---|---|---|---|---|---|
| 3896 | 2 | NAACCR | 2018 | 18 |
NAACCR XML:
Tumor.nccnInternationalPrognosticIndex
Description
The NCCN International Prognostic Index (IPI) (previously only "IPI") is used to define risk groups for specific lymphomas using a 0-8 score range, based on age, stage, number of extranodal sites of involvement, patient's performance status and pretreatment LDH level.
Rationale
NCCN International Prognostic Index (IPI) is a Registry Data Collection Variable in AJCC. It was previously collected for Lymphomas, SSF# 3.
Codes
| 00-08 | 0-8 points |
| X1 | Stated as low risk (0-1 point) |
| X2 | Stated as low intermediate risk (2-3 points) |
| X3 | Stated as intermediate risk (4-5 points) |
| X4 | Stated as high risk (6-8 points) |
| X8 | Not applicable: Information not collected for this case (If this item is required by your standard setter, use of code X8 will result in an edit error.) |
| X9 | Not documented in medical record NCCN International Prognostic Index (IPI) not assessed or unknown if assessed |
Code Notes
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.